Beykoz Life Sciences and Biotechnology Institute (BILSAB) of Bezmialem Foundation University represented Turkey at the 44th Annual Meeting of the American Society for Virology (ASV 2025), held in Montreal, Canada. ASV is one of the world's most prestigious scientific platforms in the field of virology, bringing together hundreds of leading researchers and experts from across the globe.
Sercan Keskin, a PhD student in the Biotechnology Program at the Graduate School of Health Sciences of
Bezmialem Vakıf University and a researcher at the
Institute of Life Sciences and Biotechnology (BILSAB), represented Bezmialem Vakıf University and the Doymaz Viral Immunology Laboratory at the
44th Annual Meeting of the American Society for Virology (ASV 2025), held on
July 14–17, 2025, at
McGill University, Montréal, Canada. He presented his research on an
mRNA-based vaccine candidate against Crimean–Congo Hemorrhagic Fever Virus (CCHFV) and was awarded the
ASV 2025 Student Travel Award in recognition of his scientific excellence. His participation highlighted the scientific capacity, high-quality research output, and expanding international engagement of BILSAB, Bezmialem Foundation University, reaffirming their position as active contributors to advanced virology research on the global stage.
Bezmialem Foundation University was the only university from Turkey to participate in this distinguished international meeting, marking a significant achievement for both the institution and the national scientific community.
Through participation in ASV 2025,
Beykoz Life Sciences and Biotechnology Institute (BILSAB),
Bezmialem Foundation University reaffirmed their strong commitment to strengthening international scientific collaborations, increasing the global visibility of Turkey's scientific research, and inspiring young researchers and early-career scientists to actively engage with high-impact international scientific platforms.
BILSAB continues to advance scientific excellence and foster international cooperation through active participation in leading global research forums, thereby further solidifying its contribution to the international scientific community. Such sustained international engagement reinforces
BILSAB's role as a mission-driven center for life sciences and biotechnology, with a clear commitment to high-impact research and international collaboration.
